Anti-spike T cell and antibody responses to SARS-CoV-2 mRNA vaccines in patients with hematologic malignancies

Overview of attention for article published in Blood Cancer Discovery, September 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#3 of 211)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

So far, Altmetric has seen 50 news stories from 49 outlets.

SARS-CoV-2 mRNA vaccination-induced immune responses vary among patients with hematologic malignancies, with some having a…

The LLS National Patient Registry Reports Data on T-cell Production from COVID-19 Vaccines LLS thanks the family of Michael…

Researchers have discovered a potential treatment target for Down syndrome, Th17 cells could mitigate microbiome-linked…

The LLS National Patient Registry Reports Data on T-cell Production from COVID-19 Vaccines RYE BROOK, N.Y., Sept.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 46 additional news stories.